{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:15:30Z","timestamp":1793819730003,"version":"4.6.1"},"reference-count":268,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T00:00:00Z","timestamp":1517875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"K. G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of Bergen, Bergen, Norway","award":["602805"],"award-info":[{"award-number":["602805"]}]},{"name":"European Union\u2019s Horizon 2020","award":["667302"],"award-info":[{"award-number":["667302"]}]},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"crossref","award":["5R01MH101519"],"award-info":[{"award-number":["5R01MH101519"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"crossref","award":["U01 MH109536-01"],"award-info":[{"award-number":["U01 MH109536-01"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.neubiorev.2018.02.001","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T13:22:07Z","timestamp":1518096127000},"page":"255-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":608,"special_numbering":"C","title":["The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit\/hyperactivity disorder and other psychiatric comorbidities"],"prefix":"10.1016","volume":"87","author":[{"given":"Stephen V.","family":"Faraone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0005","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00259-008-0969-9","article-title":"The effects of d-amphetamine on extrastriatal dopamine D2\/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects","volume":"36","author":"Aalto","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0969-8051(94)90007-8","article-title":"Comparison of three high affinity SPECT radiotracers for the dopamine D2 receptor","volume":"21","author":"al-Tikriti","year":"1994","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.neubiorev.2018.02.001_bib0015","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3389\/fpsyt.2017.00228","article-title":"Attention-deficit\/hyperactivity disorder and inflammation: what does current knowledge tell us? A systematic review","volume":"8","author":"Anand","year":"2017","journal-title":"Front. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0020","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/sj.npp.1300818","article-title":"Methylphenidate increases cortical excitability via activation of alpha-2 noradrenergic receptors","volume":"31","author":"Andrews","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1471-4159.2010.06898.x","article-title":"Involvement of threonine 258 and serine 259 motif in amphetamine-induced norepinephrine transporter endocytosis","volume":"115","author":"Annamalai","year":"2010","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0030","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12402-012-0088-0","article-title":"Analysis of brain metabolism by proton magnetic resonance spectroscopy (1H-MRS) in attention-deficit\/hyperactivity disorder suggests a generalized differential ontogenic pattern from controls","volume":"4","author":"Arcos-Burgos","year":"2012","journal-title":"Atten. Defic. Hyperact. Disord."},{"issue":"Suppl. 1","key":"10.1016\/j.neubiorev.2018.02.001_bib0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00023210-200923000-00005","article-title":"Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction","volume":"23","author":"Arnsten","year":"2009","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/adc.2009.175943","article-title":"NICE guideline: attention deficit hyperactivity disorder","volume":"95","author":"Atkinson","year":"2010","journal-title":"Arch. Dis. Child Educ. Pract. Ed."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0045","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/jnc.12197","article-title":"Amphetamine augments vesicular dopamine release in the dorsal and ventral striatum through different mechanisms","volume":"125","author":"Avelar","year":"2013","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib0050","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1037\/0021-843X.111.2.279","article-title":"The persistence of attention-deficit\/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder","volume":"111","author":"Barkley","year":"2002","journal-title":"J. Abnorm. Psychol."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0055","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12402-010-0039-6","article-title":"Effects of methylphenidate: the cellular point of view","volume":"2","author":"Bartl","year":"2010","journal-title":"Atten. Defic. Hyperact. Disord."},{"issue":"5","key":"10.1016\/j.neubiorev.2018.02.001_bib0060","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/DBP.0000000000000285","article-title":"Effects of methylphenidate on sleep functioning in children with attention-deficit\/hyperactivity disorder","volume":"37","author":"Becker","year":"2016","journal-title":"J. Dev. Behav. Pediatr."},{"issue":"5","key":"10.1016\/j.neubiorev.2018.02.001_bib0065","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.physbeh.2008.09.018","article-title":"Decreased behavioral activation following caffeine, amphetamine and darkness in A3 adenosine receptor knock-out mice","volume":"95","author":"Bjorklund","year":"2008","journal-title":"Physiol. Behav."},{"issue":"5","key":"10.1016\/j.neubiorev.2018.02.001_bib0070","first-page":"893","article-title":"Attention-deficit-hyperactivity disorder and reward deficiency syndrome","volume":"4","author":"Blum","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"15","key":"10.1016\/j.neubiorev.2018.02.001_bib0075","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1523\/JNEUROSCI.4370-06.2007","article-title":"Conditioned dopamine release in humans: a positron emission tomography [11C]raclopride study with amphetamine","volume":"27","author":"Boileau","year":"2007","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/0269881113519509","article-title":"Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology","volume":"28","author":"Bolea-Alamanac","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.neubiorev.2018.02.001_bib0085","first-page":"674","article-title":"Assessment of endogenous dopamine release by methylphenidate challenge using iodine-123 iodobenzamide single-photon emission tomography","volume":"24","author":"Booij","year":"1997","journal-title":"Eur. J. Nucl. Med."},{"issue":"5991","key":"10.1016\/j.neubiorev.2018.02.001_bib0090","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1126\/science.1185778","article-title":"Dopaminergic network differences in human impulsivity","volume":"329","author":"Buckholtz","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2018.02.001_bib0095","series-title":"Canadian ADHD Practice Guidelines","author":"Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA)","year":"2011"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib0100","first-page":"CD006722","article-title":"Psychostimulants for depression","author":"Candy","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/syn.10282","article-title":"Oral D-amphetamine causes prolonged displacement of [11C]raclopride as measured by PET","volume":"51","author":"Cardenas","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.neubiorev.2018.02.001_bib0110","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fgene.2016.00149","article-title":"Associations between polygenic risk for psychiatric disorders and substance involvement","volume":"7","author":"Carey","year":"2016","journal-title":"Front. Genet."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0115","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00004647-199704000-00009","article-title":"Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion","volume":"17","author":"Carson","year":"1997","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0893-133X(99)00080-9","article-title":"Behavioral changes and [123I]IBZM equilibrium SPECT measurement of amphetamine-induced dopamine release in rhesus monkeys exposed to subchronic amphetamine","volume":"22","author":"Castner","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.neubiorev.2018.02.001_bib0125","doi-asserted-by":"crossref","first-page":"e0180355","DOI":"10.1371\/journal.pone.0180355","article-title":"The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: a systematic review with network meta-analyses of randomised trials","volume":"12","author":"Catala-Lopez","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.neubiorev.2018.02.001_bib0130","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/cercor\/bht365","article-title":"Inverse effect of fluoxetine on medial prefrontal cortex activation during reward reversal in ADHD and autism","volume":"25","author":"Chantiluke","year":"2015","journal-title":"Cereb. Cortex"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neulet.2008.08.033","article-title":"Electrical stimulation modulates the amphetamine-induced hemodynamic changes: an fMRI study to compare the effect of stimulating locations and frequencies on rats","volume":"444","author":"Chen","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0140","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1124\/jpet.108.147959","article-title":"Protein kinase Cbeta is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice","volume":"328","author":"Chen","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.neubiorev.2018.02.001_bib0145","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/npp.2013.349","article-title":"Amphetamine-induced dopamine release and neurocognitive function in treatment-naive adults with ADHD","volume":"39","author":"Cherkasova","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0150","first-page":"565","article-title":"Amphetamine increases phosphorylation of extracellular signal-regulated kinase and transcription factors in the rat striatum via group I metabotropic glutamate receptors","volume":"27","author":"Choe","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib0155","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/1098-2396(200011)38:2<138::AID-SYN4>3.0.CO;2-7","article-title":"Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET study","volume":"38","author":"Chou","year":"2000","journal-title":"Synapse"},{"issue":"15","key":"10.1016\/j.neubiorev.2018.02.001_bib0160","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1523\/JNEUROSCI.3266-08.2009","article-title":"Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory","volume":"29","author":"Clatworthy","year":"2009","journal-title":"J. Neurosci."},{"issue":"49","key":"10.1016\/j.neubiorev.2018.02.001_bib0165","doi-asserted-by":"crossref","first-page":"17753","DOI":"10.1523\/JNEUROSCI.3272-12.2012","article-title":"Altered functional brain connectivity in a non-clinical sample of young adults with attention-deficit\/hyperactivity disorder","volume":"32","author":"Cocchi","year":"2012","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.neubiorev.2018.02.001_bib0170","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.smrv.2004.06.002","article-title":"Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies","volume":"8","author":"Cohen-Zion","year":"2004","journal-title":"Sleep Med. Rev."},{"issue":"5","key":"10.1016\/j.neubiorev.2018.02.001_bib0175","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.biopsych.2012.01.027","article-title":"Endogenous opioid release in the human brain reward system induced by acute amphetamine administration","volume":"72","author":"Colasanti","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2018.02.001_bib0180","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.euroneuro.2012.05.006","article-title":"Pharmacogenetics of response to methylphenidate in adult patients with attention-deficit\/hyperactivity disorder (ADHD): a systematic review","volume":"23","author":"Contini","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"20","key":"10.1016\/j.neubiorev.2018.02.001_bib0185","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1056\/NEJMoa1110212","article-title":"ADHD drugs and serious cardiovascular events in children and young adults","volume":"365","author":"Cooper","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.neubiorev.2018.02.001_bib0190","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejpn.2012.01.009","article-title":"The neurobiology and genetics of attention-deficit\/hyperactivity disorder (ADHD): what every clinician should know","volume":"16","author":"Cortese","year":"2012","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"5","key":"10.1016\/j.neubiorev.2018.02.001_bib0195","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s11920-012-0310-y","article-title":"Neuroimaging of attention-deficit\/hyperactivity disorder: current neuroscience-informed perspectives for clinicians","volume":"14","author":"Cortese","year":"2012","journal-title":"Curr. Psychiatry Rep."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0200","doi-asserted-by":"crossref","first-page":"e013967","DOI":"10.1136\/bmjopen-2016-013967","article-title":"Comparative efficacy and tolerability of pharmacological interventions for attention-deficit\/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis","volume":"7","author":"Cortese","year":"2017","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.neubiorev.2018.02.001_bib0205","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.biopsych.2016.06.014","article-title":"Functional decoding and meta-analytic connectivity modeling in adult attention-deficit\/hyperactivity disorder","volume":"80","author":"Cortese","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2018.02.001_bib0210","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/cercor\/bhs107","article-title":"Methylphenidate effects on neural activity during response inhibition in healthy humans","volume":"23","author":"Costa","year":"2013","journal-title":"Cereb. Cortex"},{"issue":"5","key":"10.1016\/j.neubiorev.2018.02.001_bib0215","doi-asserted-by":"crossref","first-page":"e60763","DOI":"10.1371\/journal.pone.0060763","article-title":"Amphetamine elicits opposing actions on readily releasable and reserve pools for dopamine","volume":"8","author":"Covey","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.neubiorev.2018.02.001_bib0220","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/syn.20506","article-title":"Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans","volume":"62","author":"Cropley","year":"2008","journal-title":"Synapse"},{"issue":"8","key":"10.1016\/j.neubiorev.2018.02.001_bib0225","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/RLU.0b013e318219b49d","article-title":"Attention deficit\/hyperactivity disorder: is there a correlation between dopamine transporter density and cerebral blood flow?","volume":"36","author":"da Silva","year":"2011","journal-title":"Clin. Nucl. Med."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0230","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.addbeh.2013.09.002","article-title":"ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study","volume":"39","author":"Dalsgaard","year":"2014","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neubiorev.2018.02.001_bib0235","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ejphar.2015.07.044","article-title":"Psychostimulants affect dopamine transmission through both dopamine transporter-dependent and independent mechanisms","volume":"764","author":"dela Pena","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0240","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1017\/S1461145712000326","article-title":"Use of adjunctive stimulants in adult bipolar depression","volume":"16","author":"Dell\u2019Osso","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0245","first-page":"535","article-title":"Regional cerebral blood flow response to oral amphetamine challenge in healthy volunteers","volume":"42","author":"Devous","year":"2001","journal-title":"J. Nucl. Med."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0250","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/syn.890130407","article-title":"Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels","volume":"13","author":"Dewey","year":"1993","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib0255","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/syn.890180207","article-title":"Pharmacokinetics and in vivo specificity of [11C]dl-threo-methylphenidate for the presynaptic dopaminergic neuron","volume":"18","author":"Ding","year":"1994","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0260","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s002130050267","article-title":"Chiral drugs: comparison of the pharmacokinetics of [11C]d-threo and l-threo-methylphenidate in the human and baboon brain","volume":"131","author":"Ding","year":"1997","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib0265","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neuropharm.2004.10.006","article-title":"Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI","volume":"48","author":"Dixon","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2018.02.001_bib0270","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fpsyt.2011.00065","article-title":"Adults with attention-deficit\/hyperactivity disorder - a brain magnetic resonance spectroscopy study","volume":"2","author":"Dramsdahl","year":"2011","journal-title":"Front. Psychiatry"},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0275","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s002590050396","article-title":"In vivo imaging of serotonin transporters with [99mTc]TRODAT-1 in nonhuman primates","volume":"26","author":"Dresel","year":"1999","journal-title":"Eur. J. Nucl. Med."},{"issue":"10","key":"10.1016\/j.neubiorev.2018.02.001_bib0280","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1007\/s002590000330","article-title":"Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment","volume":"27","author":"Dresel","year":"2000","journal-title":"Eur J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.neubiorev.2018.02.001_bib0285","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0893-133X(99)00079-2","article-title":"PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum","volume":"21","author":"Drevets","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib0290","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0006-3223(00)01038-6","article-title":"Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria","volume":"49","author":"Drevets","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2018.02.001_bib0295","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1517\/17425255.2012.671295","article-title":"Metabolic, toxicological, and safety considerations for drugs used to treat ADHD","volume":"8","author":"Duong","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"2-3","key":"10.1016\/j.neubiorev.2018.02.001_bib0300","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0014-2999(92)90703-7","article-title":"Chronic d-amphetamine inhibits opioid receptor antagonist-induced supersensitivity","volume":"221","author":"Duttaroy","year":"1992","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0305","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00213-007-0756-5","article-title":"Differential effects of the D- and L-isomers of amphetamine on pharmacological MRI BOLD contrast in the rat","volume":"193","author":"Easton","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib0310","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.neuropharm.2006.07.035","article-title":"Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain","volume":"52","author":"Easton","year":"2007","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0315","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ng.1013","article-title":"Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder","volume":"44","author":"Elia","year":"2011","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0320","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00787-009-0054-3","article-title":"Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis","volume":"19","author":"Faraone","year":"2010","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neubiorev.2018.02.001_bib0325","doi-asserted-by":"crossref","first-page":"754","DOI":"10.4088\/JCP.08m04902pur","article-title":"A comparison of the efficacy of medications for adult attention-deficit\/hyperactivity disorder using meta-analysis of effect sizes","volume":"71","author":"Faraone","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib0330","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1017\/S003329170500471X","article-title":"The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies","volume":"36","author":"Faraone","year":"2006","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neubiorev.2018.02.001_bib0335","doi-asserted-by":"crossref","first-page":"15020","DOI":"10.1038\/nrdp.2015.20","article-title":"Attention-deficit\/hyperactivity disorder","volume":"1","author":"Faraone","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0340","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1124\/pr.114.009126","article-title":"Targeting the modulation of neural circuitry for the treatment of anxiety disorders","volume":"66","author":"Farb","year":"2014","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.neubiorev.2018.02.001_bib0345","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1192\/bjp.bp.106.034389","article-title":"Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder","volume":"190","author":"Fayyad","year":"2007","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0350","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.biopsych.2004.11.030","article-title":"Actions of methylphenidate on dopaminergic neurons of the ventral midbrain","volume":"57","author":"Federici","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyu081","article-title":"Amphetamine decreases alpha2C-adrenoceptor binding of [11C]ORM-13070: a PET study in the primate brain","volume":"18","author":"Finnema","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0360","first-page":"144","article-title":"SPECT imaging of dopamine transporter sites in normal and MPTP-treated rhesus monkeys","volume":"38","author":"Fischman","year":"1997","journal-title":"J. Nucl. Med."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0365","first-page":"57","article-title":"A systematic review of augmentation strategies for patients with major depressive disorder","volume":"42","author":"Fleurence","year":"2009","journal-title":"Psychopharmacol. Bull."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0370","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0304-3940(96)12963-3","article-title":"Amphetamine releases dopamine from synaptic vesicles by dual mechanisms","volume":"215","author":"Floor","year":"1996","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0375","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1176\/appi.ajp.2011.11060940","article-title":"Striatal dopamine transporter alterations in ADHD: pathophysiology or adaptation to psychostimulants? A meta-analysis","volume":"169","author":"Fusar-Poli","year":"2012","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0380","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/npp.2013.286","article-title":"Imaging nicotine- and amphetamine-induced dopamine release in rhesus monkeys with [(11)C]PHNO vs [(11)C]raclopride PET","volume":"39","author":"Gallezot","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.neubiorev.2018.02.001_bib0385","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jaac.2010.06.015","article-title":"Methylphenidate and atomoxetine enhance prefrontal function through alpha2-adrenergic and dopamine D1 receptors","volume":"49","author":"Gamo","year":"2010","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0390","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4088\/JCP.09m05189ecr","article-title":"Sharing and selling of prescription medications in a college student sample","volume":"71","author":"Garnier","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"24","key":"10.1016\/j.neubiorev.2018.02.001_bib0395","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.1073\/pnas.1504090112","article-title":"Amphetamine modulates brain signal variability and working memory in younger and older adults","volume":"112","author":"Garrett","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib0400","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0014-2999(95)00233-B","article-title":"Binding of d-threo-[11C]methylphenidate to the dopamine transporter in vivo: insensitivity to synaptic dopamine","volume":"281","author":"Gatley","year":"1995","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0405","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s002130051093","article-title":"Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans","volume":"146","author":"Gatley","year":"1999","journal-title":"Psychopharmacology (Berl.)"},{"issue":"12","key":"10.1016\/j.neubiorev.2018.02.001_bib0410","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0024-3205(96)00052-5","article-title":"Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters","volume":"58","author":"Gatley","year":"1996","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib0415","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/(SICI)1098-2396(199902)31:2<154::AID-SYN9>3.0.CO;2-K","article-title":"Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates","volume":"31","author":"Ginovart","year":"1999","journal-title":"Synapse"},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0420","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1017\/S1461145712000818","article-title":"Effects of amphetamine on the human brain opioid system-a positron emission tomography study","volume":"16","author":"Guterstam","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"24","key":"10.1016\/j.neubiorev.2018.02.001_bib0425","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.2011.1830","article-title":"ADHD medications and risk of serious cardiovascular events in young and middle-aged adults","volume":"306","author":"Habel","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0430","doi-asserted-by":"crossref","first-page":"7","DOI":"10.31887\/DCNS.2016.18.1\/shaber","article-title":"Corticostriatal circuitry","volume":"18","author":"Haber","year":"2016","journal-title":"Dialogues Clin. Neurosci."},{"issue":"9","key":"10.1016\/j.neubiorev.2018.02.001_bib0435","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.biopsych.2010.06.017","article-title":"Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo","volume":"68","author":"Hannestad","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2018.02.001_bib0440","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0893-133X(02)00373-1","article-title":"Dextroamphetamine modulates the response of the human amygdala","volume":"27","author":"Hariri","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.neubiorev.2018.02.001_bib0445","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.neubiorev.2012.08.003","article-title":"Meta-analysis of fMRI studies of timing in attention-deficit hyperactivity disorder (ADHD)","volume":"36","author":"Hart","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"4\u20135","key":"10.1016\/j.neubiorev.2018.02.001_bib0450","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF01277655","article-title":"Amphetamine effects on dopamine release and synthesis rate studied in the rhesus monkey brain by positron emission tomography","volume":"104","author":"Hartvig","year":"1997","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"6","key":"10.1016\/j.neubiorev.2018.02.001_bib0455","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/0269881113482532","article-title":"Amphetamine, past and present--a pharmacological and clinical perspective","volume":"27","author":"Heal","year":"2013","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0460","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/0004867416676369","article-title":"Why do stimulants not work in typical depression?","volume":"51","author":"Hegerl","year":"2017","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0465","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0165-1781(82)90072-5","article-title":"Amphetamine-induced hypolocomotion in mice with more brain D2 dopamine receptors","volume":"7","author":"Helmeste","year":"1982","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neubiorev.2018.02.001_bib0470","article-title":"Why is there selective subcortical vulnerability in ADHD? Clues from postmortem brain gene expression data","author":"Hess","year":"2017","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0475","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S2215-0366(17)30049-4","article-title":"Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis","volume":"4","author":"Hoogman","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0480","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0006-8993(79)90206-3","article-title":"Acute and chronic amphetamine treatments modulate striatal dopamine receptor binding sites","volume":"161","author":"Howlett","year":"1979","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0485","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0165-3806(96)00172-1","article-title":"Amphetamine-induced preprodynorphin mRNA expression and kappa-opioid receptor binding in basal ganglia of adult rats after prenatal exposure to diazepam","volume":"98","author":"Inderbitzin","year":"1997","journal-title":"Brain Res. Dev. Brain Res."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0490","article-title":"Current and investigational medication delivery systems for treating attention-deficit\/hyperactivity disorder","volume":"18","author":"Jain","year":"2016","journal-title":"Prim. Care Companion CNS Disord."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0495","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/jnc.12743","article-title":"Amphetamine-induced release of dopamine in primate prefrontal cortex and striatum: striking differences in magnitude and timecourse","volume":"130","author":"Jedema","year":"2014","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.neubiorev.2018.02.001_bib0500","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00787-017-0962-6","article-title":"Comparative efficacy and safety of attention-deficit\/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison","volume":"26","author":"Joseph","year":"2017","journal-title":"Eur. Child Adolesc. Psychiatry"},{"issue":"11","key":"10.1016\/j.neubiorev.2018.02.001_bib0505","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1177\/1087054713510354","article-title":"Oxidative stress and ADHD: a meta-analysis","volume":"19","author":"Joseph","year":"2015","journal-title":"J. Atten. Disord."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0510","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00213-006-0550-9","article-title":"Adderall produces increased striatal dopamine release and a prolonged time course compared to amphetamine isomers","volume":"191","author":"Joyce","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0515","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/syn.21803","article-title":"Pharmacological MRI response to a selective dopamine transporter inhibitor, GBR12909, in awake and anesthetized rats","volume":"69","author":"Kashiwagi","year":"2015","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0520","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/npp.2014.240","article-title":"Methylphenidate effects on brain activity as a function of SLC6A3 genotype and striatal dopamine transporter availability","volume":"40","author":"Kasparbauer","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0525","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/(SICI)1098-2396(19990315)31:4<302::AID-SYN9>3.0.CO;2-A","article-title":"Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans","volume":"31","author":"Kegeles","year":"1999","journal-title":"Synapse"},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0530","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1176\/ajp.2006.163.4.716","article-title":"The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity survey replication","volume":"163","author":"Kessler","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2018.02.001_bib0535","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1542\/peds.2015-1708","article-title":"Stimulant medications and sleep for youth with ADHD: a meta-analysis","volume":"136","author":"Kidwell","year":"2015","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0540","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejphar.2011.01.008","article-title":"Increased in vivo [11C]raclopride binding to brain dopamine receptors in amphetamine-treated rats","volume":"654","author":"Kilbourn","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib0545","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.neuron.2004.06.030","article-title":"Amphetamine modulates human incentive processing","volume":"43","author":"Knutson","year":"2004","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.neubiorev.2018.02.001_bib0550","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.sleep.2010.02.012","article-title":"Sleep and ADHD","volume":"11","author":"Konofal","year":"2010","journal-title":"Sleep Med."},{"issue":"13","key":"10.1016\/j.neubiorev.2018.02.001_bib0555","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1523\/JNEUROSCI.16-13-04231.1996","article-title":"Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium","volume":"16","author":"Konradi","year":"1996","journal-title":"J. Neurosci."},{"issue":"1-2","key":"10.1016\/j.neubiorev.2018.02.001_bib0560","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.drugalcdep.2009.11.006","article-title":"Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study","volume":"108","author":"Konstenius","year":"2010","journal-title":"Drug Alcohol. Depend."},{"issue":"Suppl. 1","key":"10.1016\/j.neubiorev.2018.02.001_bib0565","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1360-0443.2006.01586.x","article-title":"The neurobiology of addiction: a neuroadaptational view relevant for diagnosis","volume":"101","author":"Koob","year":"2006","journal-title":"Addiction"},{"issue":"5 Suppl","key":"10.1016\/j.neubiorev.2018.02.001_bib0570","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1177\/1087054711435361","article-title":"Distinguishing comorbidity and successful management of adult ADHD","volume":"16","author":"Kooij","year":"2012","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.neubiorev.2018.02.001_bib0575","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-244X-10-67","article-title":"European consensus statement on diagnosis and treatment of adult ADHD: the European Network Adult ADHD","volume":"10","author":"Kooij","year":"2010","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib0580","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3940(00)01040-5","article-title":"Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography","volume":"285","author":"Krause","year":"2000","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.neubiorev.2018.02.001_bib0585","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00406-005-0602-x","article-title":"Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD","volume":"255","author":"Krause","year":"2005","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.neubiorev.2018.02.001_bib0590","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1046\/j.1471-4159.1997.68052032.x","article-title":"Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine","volume":"68","author":"Kuczenski","year":"1997","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.neubiorev.2018.02.001_bib0595","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/01.mnm.0000230077.48480.68","article-title":"Value of 99mTc-TRODAT-1 SPECT to predict clinical response to methylphenidate treatment in adults with attention deficit hyperactivity disorder","volume":"27","author":"la Fougere","year":"2006","journal-title":"Nucl. Med. Commun."},{"issue":"11","key":"10.1016\/j.neubiorev.2018.02.001_bib0600","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1176\/ajp.151.11.1673","article-title":"DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents","volume":"151","author":"Lahey","year":"1994","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.neubiorev.2018.02.001_bib0605","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0278-5846(99)00064-0","article-title":"Effect of amphetamine, alpha-methyl-p-tyrosine (alpha-MPT) and antipsychotic agents on dopamine D2-type receptor occupancy in rats","volume":"23","author":"Lahti","year":"1999","journal-title":"Prog. Neuropsychopharmacol. Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0610","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-011-2632-6","article-title":"Amphetamine challenge decreases yohimbine binding to alpha2 adrenoceptors in Landrace pig brain","volume":"222","author":"Landau","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"issue":"10","key":"10.1016\/j.neubiorev.2018.02.001_bib0615","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1176\/ajp.153.10.1249","article-title":"Images in neuroscience. SPECT imaging of synaptic dopamine","volume":"153","author":"Laruelle","year":"1996","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-2396(199701)25:1<1::AID-SYN1>3.0.CO;2-H","article-title":"Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates","volume":"25","author":"Laruelle","year":"1997","journal-title":"Synapse"},{"issue":"7","key":"10.1016\/j.neubiorev.2018.02.001_bib0625","first-page":"1182","article-title":"SPECT imaging of striatal dopamine release after amphetamine challenge","volume":"36","author":"Laruelle","year":"1995","journal-title":"J. Nucl. Med."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib0630","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/syn.10285","article-title":"Tyrosine-free amino acid mixture attenuates amphetamine-induced displacement of [11C]raclopride in striatum in vivo: a rat PET study","volume":"51","author":"Le Masurier","year":"2004","journal-title":"Synapse"},{"issue":"12","key":"10.1016\/j.neubiorev.2018.02.001_bib0635","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1586\/14737175.7.12.1799","article-title":"Sleep problems associated with ADHD: a review of current therapeutic options and recommendations for the future","volume":"7","author":"Lecendreux","year":"2007","journal-title":"Expert Rev. Neurother."},{"issue":"6","key":"10.1016\/j.neubiorev.2018.02.001_bib0640","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/jamapsychiatry.2015.41","article-title":"Extended-release mixed amphetamine salts vs placebo for comorbid adult attention-deficit\/hyperactivity disorder and cocaine use disorder: a randomized clinical trial","volume":"72","author":"Levin","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2018.02.001_bib0645","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0893-133X(02)00366-4","article-title":"Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET\/[11C]raclopride study in healthy men","volume":"27","author":"Leyton","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib0650","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.npp.1300328","article-title":"Decreasing amphetamine-induced dopamine release by acute phenylalanine\/tyrosine depletion: a PET\/[11C]raclopride study in healthy men","volume":"29","author":"Leyton","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2004.08.007","article-title":"Mapping the amphetamine-evoked dopamine release in the brain of the Gottingen minipig","volume":"65","author":"Lind","year":"2005","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0660","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-2999(02)02870-4","article-title":"Amphetamine enhances Ca2+ entry and catecholamine release via nicotinic receptor activation in bovine adrenal chromaffin cells","volume":"460","author":"Liu","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2018.02.001_bib0665","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.neuroimage.2008.02.025","article-title":"Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study","volume":"41","author":"Ludolph","year":"2008","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0670","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/0004867416634208","article-title":"Stimulants for depression: on the up and up?","volume":"50","author":"Malhi","year":"2016","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2018.02.001_bib0675","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1038\/tp.2014.11","article-title":"Glutamate\/glutamine and neuronal integrity in adults with ADHD: a proton MRS study","volume":"4","author":"Maltezos","year":"2014","journal-title":"Transl. Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2018.02.001_bib0680","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3810\/pgm.2014.09.2799","article-title":"Comorbidities in adult attention-deficit\/hyperactivity disorder: a practical guide to diagnosis in primary care","volume":"126","author":"Mao","year":"2014","journal-title":"Postgrad. Med."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib0685","first-page":"123","article-title":"The psychostimulant d-threo-(R,R)-methylphenidate binds as an agonist to the 5HT(1A) receptor","volume":"64","author":"Markowitz","year":"2009","journal-title":"Pharmazie"},{"issue":"6","key":"10.1016\/j.neubiorev.2018.02.001_bib0690","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1089\/cap.2006.16.687","article-title":"A comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: an exploratory study","volume":"16","author":"Markowitz","year":"2006","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0695","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01.WCB.0000048520.34839.1A","article-title":"Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum","volume":"23","author":"Martinez","year":"2003","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0700","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/2042098616679636","article-title":"Attention-deficit hyperactivity disorder medication use: factors involved in prescribing, safety aspects and outcomes","volume":"8","author":"Martinez-Raga","year":"2017","journal-title":"Ther. Adv. Drug Saf."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0705","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1471-4159.1988.tb03069.x","article-title":"Differentiation of dopamine overflow and uptake processes in the extracellular fluid of the rat caudate nucleus with fast-scan in vivo voltammetry","volume":"51","author":"May","year":"1988","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0710","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/JCP.0000000000000723","article-title":"The efficacy of psychostimulants in major depressive episodes: a systematic review and meta-analysis","volume":"37","author":"McIntyre","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0715","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1460-9568.2010.07319.x","article-title":"Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate","volume":"32","author":"Michaelides","year":"2010","journal-title":"Eur. J. Neurosci."},{"issue":"12","key":"10.1016\/j.neubiorev.2018.02.001_bib0720","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1017\/S1461145714000704","article-title":"Amphetamine induced endogenous opioid release in the human brain detected with [11C]carfentanil PET: replication in an independent cohort","volume":"17","author":"Mick","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"10","key":"10.1016\/j.neubiorev.2018.02.001_bib0725","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/0006-2952(80)90429-3","article-title":"In vivo monoamine oxidase inhibition by d-amphetamine","volume":"29","author":"Miller","year":"1980","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0730","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/cercor\/bhs345","article-title":"Methylphenidate enhances executive function and optimizes prefrontal function in both health and cocaine addiction","volume":"24","author":"Moeller","year":"2014","journal-title":"Cereb. Cortex"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib0735","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.jcbfm.9600339","article-title":"Measurement of methylphenidate-induced change in extrastriatal dopamine concentration using [11C]FLB 457 PET","volume":"27","author":"Montgomery","year":"2007","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0740","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00702-016-1623-5","article-title":"Effects of acute doses of methylphenidate on inflammation and oxidative stress in isolated hippocampus and cerebral cortex of adult rats","volume":"124","author":"Motaghinejad","year":"2017","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.neubiorev.2018.02.001_bib0745","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neulet.2015.12.015","article-title":"Effects of chronic treatment with methylphenidate on oxidative stress and inflammation in hippocampus of adult rats","volume":"619","author":"Motaghinejad","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"11","key":"10.1016\/j.neubiorev.2018.02.001_bib0750","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1002\/hbm.22557","article-title":"The effects of methylphenidate on whole brain intrinsic functional connectivity","volume":"35","author":"Mueller","year":"2014","journal-title":"Hum. Brain Mapp."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0755","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-2396(199709)27:1<1::AID-SYN1>3.0.CO;2-9","article-title":"Evaluation of d-amphetamine effects on the binding of dopamine D-2 receptor radioligand, 18F-fallypride in nonhuman primates using positron emission tomography","volume":"27","author":"Mukherjee","year":"1997","journal-title":"Synapse"},{"issue":"11","key":"10.1016\/j.neubiorev.2018.02.001_bib0760","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1176\/appi.ajp.2011.11020281","article-title":"Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication","volume":"168","author":"Nakao","year":"2011","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2018.02.001_bib0765","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/syn.20628","article-title":"Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2\/3 radiotracers [11C]FLB 457 and [11C]fallypride","volume":"63","author":"Narendran","year":"2009","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib0770","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/jpet.109.163501","article-title":"A comparative evaluation of the dopamine D(2\/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum","volume":"333","author":"Narendran","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0775","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1744-6171.2012.00322.x","article-title":"Exploring the relationship among ADHD, stimulants, and substance abuse","volume":"25","author":"Nelson","year":"2012","journal-title":"J. Child Adolesc. Psychiatr. Nurs."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0780","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00259-004-1615-9","article-title":"Quantitation of dopamine transporter blockade by methylphenidate: first in vivo investigation using [123I]FP-CIT and a dedicated small animal SPECT","volume":"32","author":"Nikolaus","year":"2005","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0785","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/MNM.0b013e328014a0df","article-title":"In-vivo quantification of dose-dependent dopamine transporter blockade in the rat striatum with small animal SPECT","volume":"28","author":"Nikolaus","year":"2007","journal-title":"Nucl. Med. Commun."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0790","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s00259-010-1668-x","article-title":"Binding of [123I]iodobenzamide to the rat D2 receptor after challenge with various doses of methylphenidate: an in vivo imaging study with dedicated small animal SPECT","volume":"38","author":"Nikolaus","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0795","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/sj.npp.1300667","article-title":"Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine","volume":"30","author":"Oswald","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2018.02.001_bib0800","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neuroimage.2015.03.022","article-title":"Risky decision-making and ventral striatal dopamine responses to amphetamine: a positron emission tomography [(11)C]raclopride study in healthy adults","volume":"113","author":"Oswald","year":"2015","journal-title":"Neuroimage"},{"issue":"10","key":"10.1016\/j.neubiorev.2018.02.001_bib0805","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1089\/cap.2016.0083","article-title":"Effect of Aptensio XR (methylphenidate HCl extended-release) capsules on sleep in children with attention-deficit\/hyperactivity disorder","volume":"26","author":"Owens","year":"2016","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.neubiorev.2018.02.001_bib0810","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11606-011-1633-9","article-title":"Different black box warning labeling for same-class drugs","volume":"26","author":"Panagiotou","year":"2011","journal-title":"J. Gen. Intern. Med."},{"issue":"14","key":"10.1016\/j.neubiorev.2018.02.001_bib0815","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1017\/S003329171500094X","article-title":"Associations between serotonin transporter gene (SLC6A4) methylation and clinical characteristics and cortical thickness in children with ADHD","volume":"45","author":"Park","year":"2015","journal-title":"Psychol. Med."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0820","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0022-3565(25)32591-7","article-title":"Effects of in vivo amphetamine administration on dopamine synthesis regulation in rat brain striatal synaptosomes","volume":"217","author":"Patrick","year":"1981","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0825","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuroimage.2006.11.038","article-title":"Mapping the amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: modulation by MAO-inhibition","volume":"35","author":"Pedersen","year":"2007","journal-title":"Neuroimage"},{"issue":"7","key":"10.1016\/j.neubiorev.2018.02.001_bib0830","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/chi.0b013e318054e724","article-title":"Practice parameter for the assessment and treatment of children and adolescents with attention-deficit\/hyperactivity disorder","volume":"46","author":"Pliszka","year":"2007","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2018.02.001_bib0835","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1176\/ajp.2007.164.6.942","article-title":"The worldwide prevalence of ADHD: a systematic review and metaregression analysis","volume":"164","author":"Polanczyk","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.neubiorev.2018.02.001_bib0840","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s40263-014-0208-9","article-title":"Targeting the nicotinic cholinergic system to treat attention-deficit\/hyperactivity disorder: rationale and progress to date","volume":"28","author":"Potter","year":"2014","journal-title":"CNS Drugs"},{"issue":"11","key":"10.1016\/j.neubiorev.2018.02.001_bib0845","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/syn.20442","article-title":"Region-specific effects of a tyrosine-free amino acid mixture on amphetamine-induced changes in BOLD fMRI signal in the rat brain","volume":"61","author":"Preece","year":"2007","journal-title":"Synapse"},{"issue":"8","key":"10.1016\/j.neubiorev.2018.02.001_bib0850","first-page":"1090","article-title":"Sequential H(2)(15)O PET studies in baboons: before and after amphetamine","volume":"43","author":"Price","year":"2002","journal-title":"J. Nucl. Med."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0855","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00213-007-0791-2","article-title":"Dissociating effects of cocaine and d-amphetamine on dopamine and serotonin in the perirhinal, entorhinal, and prefrontal cortex of freely moving rats","volume":"193","author":"Pum","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"issue":"5 Pt 2","key":"10.1016\/j.neubiorev.2018.02.001_bib0860","doi-asserted-by":"crossref","first-page":"69R","DOI":"10.1203\/PDR.0b013e318212b40f","article-title":"Neurobiology of attention deficit\/hyperactivity disorder","volume":"69","author":"Purper-Ouakil","year":"2011","journal-title":"Pediatr. Res."},{"issue":"10","key":"10.1016\/j.neubiorev.2018.02.001_bib0865","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/jcbfm.2014.117","article-title":"Imaging endogenous opioid peptide release with [11C]carfentanil and [3H]diprenorphine: influence of agonist-induced internalization","volume":"34","author":"Quelch","year":"2014","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib0870","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/1087054708320414","article-title":"The misuse and diversion of prescribed ADHD medications by college students","volume":"13","author":"Rabiner","year":"2009","journal-title":"J. Atten. Disord."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib0875","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00213-013-3105-x","article-title":"Methylphenidate reduces functional connectivity of nucleus accumbens in brain reward circuit","volume":"229","author":"Ramaekers","year":"2013","journal-title":"Psychopharmacology (Berl.)"},{"issue":"6","key":"10.1016\/j.neubiorev.2018.02.001_bib0880","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/hup.2258","article-title":"Methylphenidate-mediated reduction in prefrontal hemodynamic responses to working memory task: a functional near-infrared spectroscopy study","volume":"27","author":"Ramasubbu","year":"2012","journal-title":"Hum. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.neubiorev.2018.02.001_bib0885","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/syn.20659","article-title":"Dopaminergic response to graded dopamine concentration elicited by four amphetamine doses","volume":"63","author":"Ren","year":"2009","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib0890","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/syn.20822","article-title":"Sex differences in the relationship of regional dopamine release to affect and cognitive function in striatal and extrastriatal regions using positron emission tomography and [18F]fallypride","volume":"65","author":"Riccardi","year":"2011","journal-title":"Synapse"},{"issue":"9","key":"10.1016\/j.neubiorev.2018.02.001_bib0895","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1176\/ajp.2006.163.9.1639","article-title":"Sex differences in amphetamine-induced displacement of [18F]fallypride in striatal and extrastriatal regions: a PET study","volume":"163","author":"Riccardi","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2018.02.001_bib0900","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.npp.1300916","article-title":"Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans","volume":"31","author":"Riccardi","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2018.02.001_bib0905","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jad.2016.07.006","article-title":"Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies","volume":"206","author":"Richards","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.neubiorev.2018.02.001_bib0910","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1177\/0269881117722998","article-title":"A randomized, double-blind, placebo-controlled, dose-ranging study of lisdexamfetamine dimesylate augmentation for major depressive disorder in adults with inadequate response to antidepressant therapy","volume":"31","author":"Richards","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0915","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2007.05.044","article-title":"Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2","volume":"571","author":"Riddle","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0920","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0022-3565(25)24116-7","article-title":"Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine","volume":"248","author":"Ritz","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0925","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/jnnp.21.1.55","article-title":"A controlled trial of methyl phenidate (ritalin) in the treatment of depressive states","volume":"21","author":"Robin","year":"1958","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"23","key":"10.1016\/j.neubiorev.2018.02.001_bib0930","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1016\/0006-2952(85)90201-1","article-title":"Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors. Enantiomers of amphetamine, N-methylamphetamine and deprenyl","volume":"34","author":"Robinson","year":"1985","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0935","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/mrm.20749","article-title":"Assessment of dynamic susceptibility contrast cerebral blood flow response to amphetamine challenge: a human pharmacological magnetic resonance imaging study at 1.5 and 4 T","volume":"55","author":"Rose","year":"2006","journal-title":"Magn. Reson. Med."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib0940","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3810\/pgm.2008.09.1905","article-title":"Attention-deficit\/hyperactivity disorder in adults: evidence-based recommendations for management","volume":"120","author":"Rostain","year":"2008","journal-title":"Postgrad. Med."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib0945","first-page":"98","article-title":"Effects of haloperidol and d-amphetamine on in vivo 3H-spiroperiodol binding in the rat forebrain","volume":"246","author":"Saelens","year":"1980","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"issue":"8","key":"10.1016\/j.neubiorev.2018.02.001_bib0950","first-page":"499","article-title":"[Effects of methylphenidate on anxiety]","volume":"55","author":"Sanchez-Perez","year":"2012","journal-title":"Rev. Neurol."},{"issue":"19","key":"10.1016\/j.neubiorev.2018.02.001_bib0955","doi-asserted-by":"crossref","first-page":"8705","DOI":"10.1523\/JNEUROSCI.22-19-08705.2002","article-title":"Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors","volume":"22","author":"Sandoval","year":"2002","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.neubiorev.2018.02.001_bib0960","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2165\/11593070-000000000-00000","article-title":"Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults","volume":"25","author":"Santosh","year":"2011","journal-title":"CNS Drugs"},{"issue":"44","key":"10.1016\/j.neubiorev.2018.02.001_bib0965","doi-asserted-by":"crossref","first-page":"14769","DOI":"10.1523\/JNEUROSCI.1560-14.2014","article-title":"Acute and sustained effects of methylphenidate on cognition and presynaptic dopamine metabolism: an [18F]FDOPA PET study","volume":"34","author":"Schabram","year":"2014","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0970","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/syn.20235","article-title":"Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine","volume":"59","author":"Schiffer","year":"2006","journal-title":"Synapse"},{"issue":"5","key":"10.1016\/j.neubiorev.2018.02.001_bib0975","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/syn.20621","article-title":"Dopaminergic modulation of brain systems subserving decision making under uncertainty: a study with fMRI and methylphenidate challenge","volume":"63","author":"Schlosser","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.neubiorev.2018.02.001_bib0980","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroimage.2012.12.056","article-title":"Mapping the hemodynamic response in human subjects to a dopaminergic challenge with dextroamphetamine using ASL-based pharmacological MRI","volume":"72","author":"Schouw","year":"2013","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0985","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.psc.2015.07.002","article-title":"The neurobiology of sleep and wakefulness","volume":"38","author":"Schwartz","year":"2015","journal-title":"Psychiatr. Clin. N. Am."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib0990","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/mrm.21179","article-title":"Functional connectivity in the pharmacologically activated brain: resolving networks of correlated responses to d-amphetamine","volume":"57","author":"Schwarz","year":"2007","journal-title":"Magn. Reson. Med."},{"issue":"6","key":"10.1016\/j.neubiorev.2018.02.001_bib0995","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.mri.2007.02.017","article-title":"Pharmacological modulation of functional connectivity: the correlation structure underlying the phMRI response to d-amphetamine modified by selective dopamine D3 receptor antagonist SB277011A","volume":"25","author":"Schwarz","year":"2007","journal-title":"Magn. Reson. Imaging"},{"issue":"8","key":"10.1016\/j.neubiorev.2018.02.001_bib1000","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.biopsych.2004.07.011","article-title":"Effect of methylphenidate on executive functioning in adults with attention-deficit\/hyperactivity disorder: normalization of behavior but not related brain activity","volume":"56","author":"Schweitzer","year":"2004","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2018.02.001_bib1005","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1111\/j.1471-4159.2006.03669.x","article-title":"Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles of D1 and D2 dopamine receptors","volume":"96","author":"Schwendt","year":"2006","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.neubiorev.2018.02.001_bib1010","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.biopsych.2010.09.053","article-title":"Gray matter alterations in adults with attention-deficit\/hyperactivity disorder identified by voxel based morphometry","volume":"69","author":"Seidman","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2018.02.001_bib1015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/syn.20238","article-title":"Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride","volume":"59","author":"Seneca","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.neubiorev.2018.02.001_bib1020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.brainres.2010.02.062","article-title":"Regulation of group I metabotropic glutamate receptor expression in the rat striatum and prefrontal cortex in response to amphetamine in vivo","volume":"1326","author":"Shaffer","year":"2010","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib1025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ajmg.b.32241","article-title":"Genetic association of the tachykinin receptor 1 TACR1 gene in bipolar disorder, attention deficit hyperactivity disorder, and the alcohol dependence syndrome","volume":"165B","author":"Sharp","year":"2014","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neubiorev.2018.02.001_bib1030","doi-asserted-by":"crossref","first-page":"i2550","DOI":"10.1136\/bmj.i2550","article-title":"Cardiovascular safety of methylphenidate among children and young people with attention-deficit\/hyperactivity disorder (ADHD): nationwide self controlled case series study","volume":"353","author":"Shin","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib1035","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/jcbfm.2011.115","article-title":"Within-subject comparison of [11C]-(+)-PHNO and [11C]raclopride sensitivity to acute amphetamine challenge in healthy humans","volume":"32","author":"Shotbolt","year":"2012","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib1040","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/hbm.23071","article-title":"Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET","volume":"37","author":"Sigurdardottir","year":"2016","journal-title":"Hum. Brain Mapp."},{"issue":"8","key":"10.1016\/j.neubiorev.2018.02.001_bib1045","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/hup.434","article-title":"Dextro-amphetamine increases phosphoinositol cycle activity in volunteers: an MRS study","volume":"17","author":"Silverstone","year":"2002","journal-title":"Hum. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib1050","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1192\/bjp.bp.107.048827","article-title":"Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis","volume":"194","author":"Simon","year":"2009","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib1055","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.neuroimage.2010.01.055","article-title":"D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse model","volume":"50","author":"Skinbjerg","year":"2010","journal-title":"Neuroimage"},{"issue":"5","key":"10.1016\/j.neubiorev.2018.02.001_bib1060","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/syn.20734","article-title":"Striatal and extrastriatal dopamine release measured with PET and [18F] fallypride","volume":"64","author":"Slifstein","year":"2010","journal-title":"Synapse"},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib1065","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1523\/JNEUROSCI.4079-04.2005","article-title":"Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice","volume":"25","author":"Smith","year":"2005","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib1070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1087054713479663","article-title":"Sleep and circadian rhythmicity in adult ADHD and the effect of stimulants","volume":"21","author":"Snitselaar","year":"2017","journal-title":"J. Atten. Disord."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib1075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bcp.2013.04.013","article-title":"Adolescence methylphenidate treatment in a rodent model of attention deficit\/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood","volume":"86","author":"Somkuwar","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib1080","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1176\/appi.ajp.163.3.387","article-title":"PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate","volume":"163","author":"Spencer","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib1085","first-page":"261","article-title":"A PET study examining pharmacokinetics and dopamine transporter occupancy of two long-acting formulations of methylphenidate in adults","volume":"25","author":"Spencer","year":"2010","journal-title":"Int. J. Mol. Med."},{"issue":"9","key":"10.1016\/j.neubiorev.2018.02.001_bib1090","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.biopsych.2006.12.008","article-title":"Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane","volume":"62","author":"Spencer","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2018.02.001_bib1095","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.2147\/NDT.S111818","article-title":"Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse","volume":"12","author":"Sternat","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib1100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.31887\/DCNS.1999.1.3\/gstotz","article-title":"Psychostimulants in the therapy of treatment-resistant depression: review of the literature and findings from a retrospective study in 65 depressed patients","volume":"1","author":"Stotz","year":"1999","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2018.02.001_bib1105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jad.2015.03.006","article-title":"Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion","volume":"178","author":"Stuhec","year":"2015","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.neubiorev.2018.02.001_bib1110","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1542\/peds.2011-2654","article-title":"ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit\/hyperactivity disorder in children and adolescents","volume":"128","author":"Subcommittee on Attention-Deficit\/Hyperactivity Disorder","year":"2011","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.neubiorev.2018.02.001_bib1115","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0896-6273(90)90339-H","article-title":"Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action","volume":"5","author":"Sulzer","year":"1990","journal-title":"Neuron"},{"issue":"5 Pt 2","key":"10.1016\/j.neubiorev.2018.02.001_bib1120","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1523\/JNEUROSCI.15-05-04102.1995","article-title":"Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport","volume":"15","author":"Sulzer","year":"1995","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib1125","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1124\/mol.63.2.456","article-title":"In vivo evidence for dopamine-mediated internalization of D2-receptors after amphetamine: differential findings with [3H]raclopride versus [3H]spiperone","volume":"63","author":"Sun","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.neubiorev.2018.02.001_bib1130","doi-asserted-by":"crossref","first-page":"903","DOI":"10.4088\/JCP.11m06838","article-title":"Impact of stimulant pharmacotherapy on sleep quality: post hoc analyses of 2 large, double-blind, randomized, placebo-controlled trials","volume":"72","author":"Surman","year":"2011","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib1135","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1542\/9781581108736-adhd_diagnosis","article-title":"ADHD diagnosis and treatment in college students and young adults","volume":"24","author":"Thomas","year":"2013","journal-title":"Adolesc. Med. State Art Rev."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib1140","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/phar.1576","article-title":"Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression","volume":"35","author":"Thomas","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib1145","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1016\/j.neuroimage.2010.10.060","article-title":"Methylphenidate enhances brain activation and deactivation responses to visual attention and working memory tasks in healthy controls","volume":"54","author":"Tomasi","year":"2011","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib1150","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0197-0186(99)00103-5","article-title":"Psychotomimetics moderately affect dopamine receptor binding in the rat brain","volume":"36","author":"Tomic","year":"2000","journal-title":"Neurochem. Int."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib1155","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0924-977X(97)00398-2","article-title":"Acute amphetamine and\/or phencyclidine effects on the dopamine receptor specific binding in the rat brain","volume":"7","author":"Tomic","year":"1997","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib1160","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.neubiorev.2010.06.006","article-title":"Reconsidering anhedonia in depression: lessons from translational neuroscience","volume":"35","author":"Treadway","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib1165","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00213-005-0193-2","article-title":"Assessment of methylphenidate-induced changes in binding of continuously infused [11C]-raclopride in healthy human subjects: correlation with subjective effects","volume":"183","author":"Udo de Haes","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"issue":"5","key":"10.1016\/j.neubiorev.2018.02.001_bib1170","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/sj.npp.1300902","article-title":"Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography","volume":"31","author":"van Berckel","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib1175","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.neubiorev.2012.01.003","article-title":"Diffusion tensor imaging in attention deficit\/hyperactivity disorder: a systematic review and meta-analysis","volume":"36","author":"van Ewijk","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"12","key":"10.1016\/j.neubiorev.2018.02.001_bib1180","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jamapsychiatry.2014.1226","article-title":"The norepinephrine transporter in attention-deficit\/hyperactivity disorder investigated with positron emission tomography","volume":"71","author":"Vanicek","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib1185","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hbm.23418","article-title":"Altered interregional molecular associations of the serotonin transporter in attention deficit\/hyperactivity disorder assessed with PET","volume":"38","author":"Vanicek","year":"2017","journal-title":"Hum. Brain Mapp."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib1190","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.chc.2012.07.005","article-title":"Pharmacotherapy of pediatric attention-deficit\/hyperactivity disorder","volume":"21","author":"Vaughan","year":"2012","journal-title":"Child Adolesc. Psychiatr. Clin. N. Am."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib1195","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cell.2015.07.046","article-title":"The brain on drugs: from reward to addiction","volume":"162","author":"Volkow","year":"2015","journal-title":"Cell."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib1200","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/syn.890160402","article-title":"Imaging endogenous dopamine competition with [11C]raclopride in the human brain","volume":"16","author":"Volkow","year":"1994","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib1205","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1176\/ajp.154.1.50","article-title":"Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors","volume":"154","author":"Volkow","year":"1997","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.neubiorev.2018.02.001_bib1210","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1176\/ajp.155.10.1325","article-title":"Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate","volume":"155","author":"Volkow","year":"1998","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib1215","doi-asserted-by":"crossref","first-page":"Rc121","DOI":"10.1523\/JNEUROSCI.21-02-j0001.2001","article-title":"Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain","volume":"21","author":"Volkow","year":"2001","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.neubiorev.2018.02.001_bib1220","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1176\/appi.ajp.161.7.1173","article-title":"Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain","volume":"161","author":"Volkow","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib1225","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1523\/JNEUROSCI.4461-11.2012","article-title":"Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder","volume":"32","author":"Volkow","year":"2012","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.neubiorev.2018.02.001_bib1230","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/mp.2010.97","article-title":"Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway","volume":"16","author":"Volkow","year":"2011","journal-title":"Mol. Psychiatry"},{"issue":"19","key":"10.1016\/j.neubiorev.2018.02.001_bib1235","doi-asserted-by":"crossref","first-page":"10388","DOI":"10.1073\/pnas.93.19.10388","article-title":"Relationship between psychostimulant-induced \"high\" and dopamine transporter occupancy","volume":"93","author":"Volkow","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.neubiorev.2018.02.001_bib1240","first-page":"1242","article-title":"PET evaluation of the dopamine system of the human brain","volume":"37","author":"Volkow","year":"1996","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib1245","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/(SICI)1098-2396(199901)31:1<59::AID-SYN8>3.0.CO;2-Y","article-title":"Comparable changes in synaptic dopamine induced by methylphenidate and by cocaine in the baboon brain","volume":"31","author":"Volkow","year":"1999","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib1250","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0022-3565(24)37918-2","article-title":"Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of \u201chigh\u201d","volume":"288","author":"Volkow","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib1255","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/syn.10038","article-title":"Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications","volume":"43","author":"Volkow","year":"2002","journal-title":"Synapse"},{"issue":"Suppl. 1","key":"10.1016\/j.neubiorev.2018.02.001_bib1260","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1177\/070674370200601S05","article-title":"Mechanism of action of methylphenidate: insights from PET imaging studies","volume":"6","author":"Volkow","year":"2002","journal-title":"J. Atten. Disord."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib1265","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0925-4927(98)00033-X","article-title":"Effects of high amphetamine dose on mood and cerebral glucose metabolism in normal volunteers using positron emission tomography (PET)","volume":"83","author":"Vollenweider","year":"1998","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib1270","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0026-895X(25)08574-8","article-title":"Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux","volume":"47","author":"Wall","year":"1995","journal-title":"Mol. Pharmacol."},{"issue":"11","key":"10.1016\/j.neubiorev.2018.02.001_bib1275","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1038\/sj.npp.1301373","article-title":"Association of amphetamine-induced striatal dopamine release and cortisol responses to psychological stress","volume":"32","author":"Wand","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.neubiorev.2018.02.001_bib1280","first-page":"1285","article-title":"Reproducibility of repeated measures of endogenous dopamine competition with [11C]raclopride in the human brain in response to methylphenidate","volume":"40","author":"Wang","year":"1999","journal-title":"J. Nucl. Med."},{"issue":"5","key":"10.1016\/j.neubiorev.2018.02.001_bib1285","doi-asserted-by":"crossref","first-page":"e63023","DOI":"10.1371\/journal.pone.0063023","article-title":"Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib1290","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-7138(09)60450-7","article-title":"Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children","volume":"24","author":"Weiss","year":"1985","journal-title":"J. Am. Acad. Child Psychiatry"},{"key":"10.1016\/j.neubiorev.2018.02.001_bib1295","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2261-12-41","article-title":"Do prescription stimulants increase the risk of adverse cardiovascular events? A systematic review","volume":"12","author":"Westover","year":"2012","journal-title":"BMC Cardiovasc. Disord."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib1300","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.npp.1301400","article-title":"First human evidence of d-amphetamine induced displacement of a D2\/3 agonist radioligand: a [11C]-(+)-PHNO positron emission tomography study","volume":"33","author":"Willeit","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neubiorev.2018.02.001_bib1305","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1542\/peds.2008-3138","article-title":"Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD","volume":"124","author":"Winterstein","year":"2009","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.02.001_bib1310","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00177923","article-title":"Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography","volume":"92","author":"Wolkin","year":"1987","journal-title":"Psychopharmacology (Berl.)"},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib1315","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1176\/appi.ajp.2010.10020165","article-title":"Correlation of individual differences in schizotypal personality traits with amphetamine-induced dopamine release in striatal and extrastriatal brain regions","volume":"168","author":"Woodward","year":"2011","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib1320","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/(SICI)1098-2396(199808)29:4<379::AID-SYN10>3.0.CO;2-M","article-title":"Effects of estrogen agonists on amphetamine-stimulated striatal dopamine release","volume":"29","author":"Xiao","year":"1998","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/j.neubiorev.2018.02.001_bib1325","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.neuint.2010.06.007","article-title":"Differential changes in cerebellar transmitter content and expression of calcium binding proteins and transcription factors in mouse administered with amphetamine","volume":"57","author":"Yin","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neubiorev.2018.02.001_bib1330","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.brainres.2010.09.109","article-title":"Amphetamine alters behavior and mesocorticolimbic dopamine receptor expression in the monogamous female prairie vole","volume":"1367","author":"Young","year":"2011","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.02.001_bib1335","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/syn.10275","article-title":"Activation of metabotropic glutamate receptor 5 is associated with effect of amphetamine on brain neurons","volume":"50","author":"Yu","year":"2003","journal-title":"Synapse"},{"issue":"5","key":"10.1016\/j.neubiorev.2018.02.001_bib1340","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2174\/187152708786927877","article-title":"Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse","volume":"7","author":"Zhu","year":"2008","journal-title":"CNS Neurol. Disord. Drug Targets"}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763417308072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763417308072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T09:19:57Z","timestamp":1758964797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763417308072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":268,"alternative-id":["S0149763417308072"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2018.02.001","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit\/hyperactivity disorder and other psychiatric comorbidities","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2018.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}